We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$99B
AUM Growth
-$13.3B
Cap. Flow
-$12.9B
Cap. Flow %
-13%
Top 10 Hldgs %
11.77%
Holding
4,867
New
290
Increased
1,487
Reduced
2,300
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 10.92%
2 Financials 10.74%
3 Technology 10.54%
4 Energy 7.9%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONE
4126
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$40K ﹤0.01%
16,728
-28,960
-63% -$95K
SB icon
4127
Safe Bulkers
SB
$803M
$39K ﹤0.01%
10,831
-76,917
-88% -$278K
FLNA
4128
Filana Therapeutics
FLNA
$49.8M
$36K ﹤0.01%
2,688
-2,978
-53% -$40.2K
FCRE
4129
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$36K ﹤0.01%
3,549
-4,246
-54% -$36.3K
WINT
4130
DELISTED
Windtree Therapeutics Inc
WINT
$36K ﹤0.01%
2,189
-5,100
-70% -$100K
CNVS icon
4131
Cineverse
CNVS
$58.5M
$35K ﹤0.01%
108
-89
-45% -$27.6K
LSTA icon
4132
Lisata Therapeutics
LSTA
$9.47M
$35K ﹤0.01%
91
-227
-71% -$123K
NTIP icon
4133
Network-1 Technologies
NTIP
$37.7M
$35K ﹤0.01%
+15,700
New +$35.9K
BIOL
4134
DELISTED
Biolase, Inc.
BIOL
$35K ﹤0.01%
1
-3
-75% -$85K
COVS
4135
DELISTED
Covisint Corporation
COVS
$35K ﹤0.01%
17,480
-160,848
-90% -$375K
RVLT
4136
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$35K ﹤0.01%
3,175
-1,398
-31% -$16.2K
CDTI
4137
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
$31K ﹤0.01%
688
+42
+7% +$2K
NAVB
4138
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$29K ﹤0.01%
928
-1,787
-66% -$60.5K
AOI
4139
DELISTED
Alliance One International
AOI
$29K ﹤0.01%
2,640
-7,310
-73% -$82K
MTBL
4140
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$28K ﹤0.01%
7,741
-6,645
-46% -$25.5K
LFVN icon
4141
LifeVantage
LFVN
$83M
$27K ﹤0.01%
4,812
-10,472
-69% -$75.4K
BPTH
4142
DELISTED
Bio-Path Holdings Inc
BPTH
$27K ﹤0.01%
4
-5
-56% -$42K
XBKS
4143
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$27K ﹤0.01%
1,403
+142
+11% +$2.38K
RSYS
4144
DELISTED
Radisys Corp
RSYS
$25K ﹤0.01%
11,829
+1,100
+10% +$2.46K
QUIK icon
4145
QuickLogic
QUIK
$238M
$23K ﹤0.01%
868
-1,371
-61% -$44.2K
PCO
4146
DELISTED
Pendrell Corporation - Class A
PCO
$23K ﹤0.01%
18
-270
-94% -$324K
MY
4147
DELISTED
CHINA MING YANG WIND PWR GRP LTD ADS RSPTG 1 ORD SHS (CHINA)
MY
$23K ﹤0.01%
10,065
-4,005
-28% -$8.8K
PRKR
4148
DELISTED
Parkervision Inc
PRKR
$22K ﹤0.01%
2,667
-8,189
-75% -$79.1K
NBG
4149
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
$22K ﹤0.01%
17,038
-31,762
-65% -$46.6K
HK
4150
PUT
DELISTED
Halcon Resources Corporation
HK
$21K ﹤0.01%
78

Similar funds

Credit Suisse's Q1 2015 Portfolio in Review

As of Q1 2015, Credit Suisse held 4,867 positions worth $99B, down 12% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Credit Suisse withdrew a net $12.9B in Q1 2015, closing 529 positions and reducing 2,300 holdings. Its most notable exit was Allergan Inc, an estimated $280M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

Against the trend, Credit Suisse opened a new position in Medtronic worth $266M.

  • Credit Suisse's largest Q1 2015 buy was Medtronic: 3,416,666 shares worth $266M.
  • Credit Suisse added most to KRAFT FOODS GROUP INC COM STK (VA) in Q1 2015, an estimated $451M increase.
  • Credit Suisse's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.16B.
  • Credit Suisse fully exited Allergan Inc in Q1 2015, selling an estimated $280M.
  • Credit Suisse's ten largest holdings make up 12% of its $99B portfolio in Q1 2015.
  • Credit Suisse opened 290 new positions and closed 529 in Q1 2015.
  • Credit Suisse's portfolio value fell 12% quarter-over-quarter to $99B.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.